Precision medicine is revolutionizing healthcare by combining cancer therapeutics with selective diagnostic tests and personalizing patient treatment. Lantern pharma is pioneering precision medicine combining a clinically tested class of drugs called Irofulvens with personalized diagnostic test. Lantern will do focused clinical trials with a novel clinically tested class of drugs that act against multi-drug resistance in combination with biomarker based companion diagnostics test that prospectively identify responders for the drugs based on changes in biomarkers. Ultimately, the goal of precision cancer medicine is to improve patient outcomes, reduce developmental cost and time.

Copyright 2015 Lantern Pharma.  All rights reserved. 
designed & developed by Intuition Softwares.